BoomRx vs RxFul

BoomRx vs RxFul

BoomRx and RxFul emphasize different layers. BoomRx is a national pharmaceutical technology platform that unifies 503A, 503B, and brand medication procurement through one provider portal with consolidated flat-rate shipping, while RxFul centers on white-label patient portal infrastructure — clinic-branded checkout, licensed 503A partners, and tiered SaaS from $0 GLP through $1,997 per month. Fizy Health is a prescriber-first clinic ordering platform that shows pass-through per-vial pricing before checkout and validates orders before you pay.

If you are choosing between a provider procurement portal and a white-label patient portal like RxFul, this page compares the models and shows where a pass-through platform like Fizy Health fits.

Compare Fizy Health vs BoomRx
BoomRx vs RxFul

BoomRx vs RxFul, capability by capability.

BoomRx is a provider-facing procurement portal across 503A, 503B, and brand medications. RxFul centers on a white-label patient portal. The comparison is really prescriber procurement versus patient-facing infrastructure.

Platform model
BoomRxUnified procurement portal: 503A, 503B, and brand medications through one provider dashboard.
RxFulWhite-label patient portal plus 503A orchestration tech and 3PL logistics — not a pharmacy.
Primary user
BoomRxClinic prescribers and ops staff sourcing medications nationally.
RxFulPatients ordering through a clinic-branded portal experience.
Pricing visibility
BoomRxCompetitive pricing and dashboard visibility; procurement rates through portal after provider signup.
RxFulPricing presented in the patient-facing portal; clinic-facing per-vial rates vary by SaaS tier.
Platform cost
BoomRxOne fee narrative; pricing details behind provider signup.
RxFulTiered SaaS from $0 GLP through $1,997 per month plus fulfillment fees.
503B scope
BoomRx503A, FDA-registered 503B outsourcing, and brand medications in one dashboard.
RxFul503A orchestration through licensed partners; 503B breadth not publicly documented.
Pre-submit validation
BoomRxStandard procurement and pharmacy review rather than advertised pre-submit cart validation.
RxFulStandard portal and fulfillment review rather than advertised pre-submit cart validation.
  • When BoomRx fits

    Your team sources medications through a provider procurement portal spanning 503A, 503B, and brand meds with flat-rate consolidated shipping.

  • When RxFul fits

    Your priority is a branded patient-facing ordering portal and tiered SaaS infrastructure rather than prescriber-side batch checkout.

RxFul details from rxful.com public pricing and product pages (June 2026). BoomRx details from boomrx.com and PR Newswire (Dec 2025), reviewed June 2026.

Provider procurement or patient-facing portal?

BoomRx and RxFul take different starting points. BoomRx is built for providers and clinic staff sourcing 503A, 503B, and brand medications through one procurement portal with consolidated flat-rate shipping. RxFul centers on white-label patient portal infrastructure with tiered monthly SaaS and clinic-branded checkout.

Pick by who places the order. If your team orders on behalf of patients through a provider hub, procurement software fits. If you want patients checking out under your brand, a patient portal carries that experience — and either way, landed-cost clarity drives your margin.

Where Fizy Health changes the comparison

Fizy Health is a prescriber-first clinic ordering platform that shows resolved per-vial 503A cost on every catalog and cart line before checkout, with a disclosed facilitation fee at payment. Cart validation catches invalid SIGs, prescriber state mismatches, and stock gaps before you pay, and every patient-linked cart line is audited.

BoomRx, RxFul, or a pass-through platform — which fits your clinic?

BoomRx fits if

BoomRx

You want provider-side procurement across 503A, 503B, and brand meds.

  • Your clinicians and ops team place orders — not patients through a branded storefront.
  • You need 503B office-use and brand medication access alongside 503A in one portal.
  • Flat-rate consolidated shipping and EMR or API integrations matter for telehealth scale.
Consider Fizy Health if

Fizy Health

Pass-through per-vial pricing and validation before you pay.

  • Your team batches dozens of patient refills in one prescriber-side cart — not per-patient portal sessions.
  • You want pass-through per-vial 503A cost visible before checkout, not behind a monthly platform tier.
  • You use more than one 503A partner and want routing and tracking from one login.
FAQ

BoomRx vs RxFul questions.

  • Category

    Are BoomRx and RxFul the same kind of platform?

    No. BoomRx is a provider-facing procurement portal spanning 503A, 503B, and brand medications, while RxFul is white-label patient portal infrastructure with tiered SaaS pricing.

  • Primary user

    Who places orders on BoomRx versus RxFul?

    BoomRx is built for clinic prescribers and ops staff sourcing through a provider portal. RxFul centers on patients ordering through a clinic-branded portal. Fizy Health is prescriber-first with patient-linked cart lines.

  • Pricing

    How does platform cost differ?

    BoomRx uses a one-fee narrative with details behind provider signup. RxFul publishes tiered SaaS from $0 GLP through $1,997 per month. Fizy Health is free to start with a disclosed facilitation fee at checkout only when you order.

  • Scope

    Which covers 503B office-use bulk?

    BoomRx spans 503A, 503B, and brand medications in one portal. RxFul focuses on 503A orchestration through licensed partners. Fizy Health focuses on 503A patient-specific ordering.

  • Batch checkout

    Can either batch a full refill day in one session?

    Neither BoomRx nor RxFul publicly documents multi-patient prescriber batch checkout. Fizy Health batches every patient line in one clinic cart with one validation pass and one payment.

  • Alternative

    Where does Fizy Health fit between BoomRx and RxFul?

    Fizy Health is a prescriber-first clinic ordering platform that adds pass-through per-vial pricing before checkout, pre-submit cart validation, and per-line tracking across LegitScript-certified 503A partners.

Sources reviewed June 2026

  • RxFul public website and pricing pages (rxful.com), reviewed June 2026.
  • BoomRx public website and PR Newswire press release (Dec 2025), reviewed June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

Compare pass-through pricing against both options.

See resolved per-vial 503A cost before you quote, with validation before you pay and one cart across partners. Free to start.